Innovation requires significant investment in research and development. Companies rely on patent protection to generate returns on those investments and maintain competitive advantage. A well-constructed patent strategy provides exclusivity for up to 20 years while serving as a tool for licensing, valuation, deterrence, and strategic positioning.
Effective patent strategy requires systematic monitoring of competitor activity to detect potential infringements and ensure freedom to operate. Patent filings typically precede commercial launches, making patent monitoring a valuable source of strategic intelligence. Our team combines technical, legal, fiscal, and commercial expertise to help you maximise the value of your innovations throughout the full patent lifecycle.
The choice of filing route has significant cost and coverage implications. A Belgian national patent covers Belgium only and is granted without substantive examination (making it faster but less defensible). A European Patent is examined by the EPO and, upon grant, must be validated in each desired member state. A Unitary Patent covers all participating EU states automatically with a single renewal fee, offering the most cost-effective route for broad European coverage. The PCT (Patent Cooperation Treaty) route provides a mechanism for deferring national phase entry decisions, giving applicants up to 30 months from priority to decide which jurisdictions to enter.
We advise on the optimal combination of filing routes based on your technology, your markets, and your budget. For most European businesses, the European Patent route with selective national validation (or Unitary Patent for broad coverage) provides the best balance of examination quality, geographic reach, and cost management.
The Unified Patent Court (UPC), operational since June 2023, provides a single forum for patent disputes across participating EU member states. For patent holders, the UPC offers the ability to enforce a patent across multiple countries in a single proceeding and to obtain pan-European injunctions. For defendants, it creates the risk of centralised invalidity proceedings that can revoke a patent across all participating states simultaneously.
The opt-out decision (whether to keep existing European patents under national court jurisdiction during the transitional period) is one of the most strategically important patent management questions for any company with a European portfolio. We advise on the opt-out decision based on each patent's risk profile, competitive landscape, and enforcement priorities.
Patent prosecution (the process of obtaining a granted patent through examination) requires both technical understanding of the invention and legal skill in claim drafting and argument. Our European Patent Attorneys handle prosecution at the EPO, BOIP, and national offices, drafting claims with enforcement in mind rather than merely seeking the broadest possible scope without regard to defensibility.
Portfolio management covers the ongoing decisions that maintain and optimise a patent portfolio: annual renewal decisions, periodic review against the current business strategy, competitor monitoring, freedom-to-operate updates, and strategic decisions about licensing, abandonment, or additional filings. Our IPRHQ platform provides a unified dashboard for all portfolio management functions.
Belgian patents are typically granted within 12 to 18 months. European patents take an average of 3 to 5 years. Unitary Patents are available immediately upon grant of the underlying European Patent by requesting unitary effect within one month of grant.
The UPC is a supranational European court for patent disputes that allows patent holders to enforce rights across multiple EU jurisdictions in a single proceeding, significantly reducing litigation costs and complexity compared to parallel national actions. It also enables centralised invalidity proceedings.
Jurisdiction selection is driven by commercial factors: where products are made, sold, and used; where competitors are active; where enforcement is realistic; and where licensing revenue is possible. We model the cost-benefit for each jurisdiction and recommend a programme that maximises value within budget.
A European Patent is examined by the EPO and, upon grant, must be validated individually in each desired member state with separate national fees and renewal streams. A Unitary Patent provides automatic coverage across all participating EU states with a single renewal fee. The Unitary Patent is more cost-effective for broad coverage but carries centralised invalidity risk through the UPC.
%402x.svg){kind=icon}
%402x.svg){kind=icon}
%402x.svg){kind=small}